In life sciences and other highly regulated industries, breakthrough ideas often stall because engineers are buried in paperwork instead of advancing patient-saving technology. I launched Ketryx to change that—using AI agents to shoulder the busywork of drafting requirements, classifying complaints, and generating audit-ready documentation, while flagging risks before they reach patients. By making compliance a real-time, risk-aware safety net, we free teams to focus on and accelerate innovation. With Transformation Capital’s backing, we can bring this infrastructure to life sciences builders faster than ever. — Erez Kaminksi, CEO